registHER: An observational cohort study of patients with HER2+metastatic breast cancer

被引：0

作者：

Yood, Marianne Ulcickas ^{[1
,2
]}

Kaufman, Peter A. ^{[3
,4
]}

Mayer, Musa ^{[5
]}

Rugo, Hope ^{[6
]}

Brufsky, Adam ^{[7
]}

Tan-Chiu, Elizabeth ^{[8
]}

Yardley, Denise ^{[9
]}

Paik, Soonmyung ^{[10
]}

Wang, Lisa ^{[11
]}

Birkner, Merrill ^{[11
]}

Brammer, Melissa ^{[11
]}

Tripathy, Debu ^{[12
]}

机构：

[1] Yale Univ, Sch Med, New Haven, CT USA

[2] EpiSource, Hamden, CT USA

[3] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA

[4] Norris Cotton Canc Ctr, Lebanon, NH USA

[5] AdvancedBC Org, New York, NY USA

[6] UCSF, Ctr Comprehens Canc, San Francisco, CA USA

[7] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA USA

[8] Florida Canc Care, Tamarac, FL USA

[9] Sarah Cannon Res Inst, Nashville, TN USA

[10] Natl Surtal Breast & Bowel Project, Pittsburgh, PA USA

[11] Genentech Inc, San Francisco, CA 94080 USA

[12] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2008年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

090

引用

页码：S40 / S40

页数：1

共 50 条

[1] Survival of patients with HER2+metastatic breast cancer and use of trastuzumab following progression: analysis of RegistHER
Rugo, H.
Kaufman, P.
Tan-Chiu, E.
Ulcickas, Yood M.
Paik, S.
Yardley, D.
Brufsky, A.
Mayer, M.
Birkner, M.
Wang, L.
Brammer, M.
Tripathy, D.
CANCER RESEARCH, 2009, 69 (02) : 245S - 245S
[2] registHER: treatments and clinical outcomes from a prospective observational cohort study of patients with HER2-positive metastatic breast cancer.
Brufsky, A
Rugo, H
Tripathy, D
Kaufman, P
Mayer, M
Paik, S
Ulcickas-Yood, M
Yardley, D
Tan-Chiu, E
BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S148 - S148
[3] Treatment patterns and associated outcomes among patients with HER2+metastatic breast cancer in the United States: an observational cohort study
Lam, Clara
Varghese, Della
Collins, Jenna
Nordstrom, Beth
Murphy, Brian
Mehta, Sandhya
Faherty, Eleanor
ONCOLOGIST, 2025, 30 (04):
[4] Multicenter observational study on adherence and acceptance of lapatinib treatment in patients with HER2+metastatic breast cancer
Addeo, R.
Vincenzi, B.
Riccardi, F.
Febbraro, A.
Maiorino, L.
Incoronato, P.
Mabilia, R.
Bianco, M.
Russo, E.
Pisano, A.
Del Prete, S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[5] Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
Peter A. Kaufman
Adam M. Brufsky
Musa Mayer
Hope S. Rugo
Debu Tripathy
Marianne Ulcickas Yood
Shibao Feng
Lisa I. Wang
Cheng S. Quah
Denise A. Yardley
Breast Cancer Research and Treatment, 2012, 135 : 875 - 883
[6] registHER: A prospective, longitudinal cohort study of women with HER2 positive metastatic breast cancer.
Tanchiu, E
Kaufman, PA
Paik, S
Ulcickas-Yood, M
Mayer, M
Tripathy, D
Rugo, H
Brufsky, A
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 46S - 46S
[7] Treatment patterns and clinical outcomes in elderly patients with HER2-positive metastatic breast cancer from the registHER observational study
Kaufman, Peter A.
Brufsky, Adam M.
Mayer, Musa
Rugo, Hope S.
Tripathy, Debu
Yood, Marianne Ulcickas
Feng, Shibao
Wang, Lisa I.
Quah, Cheng S.
Yardley, Denise A.
BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 875 - 883
[8] Evolving HER2+Metastatic Breast Cancer Landscape
Seidman, Andrew D.
Bardia, Aditya
Pegram, Mark
Rao, Ruta
ONCOLOGY-NEW YORK, 2021, 35 (12): : 839 - 842
[9] Treatment Patterns and Clinical Outcomes in Elderly Patients with HER2-Positive Metastatic Breast Cancer from the registHER Observational Study.
Kaufman, P. A.
Brufsky, A. M.
Mayer, M.
Rugo, H. S.
Tripathy, D.
Ulcickas, Yood M.
Feng, S.
Wang, L. I.
Brammer, M. G.
Yardley, D. A.
CANCER RESEARCH, 2011, 71
[10] Relapsed/Refractory HER2+Metastatic Breast Cancer
Brufsky, Adam M.
Gadi, V. K.
Hurvitz, Sara A.
Iyengar, Neil M.
ONCOLOGY-NEW YORK, 2021, 35 (04): : 215 - 219

← 1 2 3 4 5 →